Australia Breaking News

Perth-based Alkane Resources (ASX:ALK) announced its financial results for the third quarter ended March 31.

Xi Jinping warned that Taiwan could lead to "clashes" between the US and China, calling it a "highly dangerous situation" for the world's biggest economies. Bloomberg's Stephen Engle breaks down the situation.

Civmec (ASX:CVL) reported a quarterly revenue of $244.2 million, contributing to a year-to-date total of $624.7 million for the first nine months.

AVITA Medical (ASX:AVH) reported its financial performance for the first quarter of 2026, headlined by a total revenue of US$19.3 million.

Pacific Edge (ASX:PEB) secured a regulatory win as Novitas publishes draft Medicare coverage for Cxbladder Triage tests.

Meridian Energy (ASX:MEZ) secured resource consent for the Bunnythorpe Solar Farm.

P&N Bank announced a proposed $30 billion tie-up with Melbourne-based Bank Australia.

Weebit Nano (ASX:WBT) has raised $15 million through a "strongly supported" share purchase plan.

Opposition Leader Angus Taylor has unveiled a "generational" reform package, pledging to index Australia’s tax brackets to inflation and slash migration.

George Mattson, CEO of private aviation company Wheels Up, said that his company is 'immunized' from the impact of fuel cost spikes because they are able to pass off surcharges to customers willing to pay a premium. Mattson discussed Delta's investment in the private sphere and said the airline company sees Wheels Up as an extension of its growing premium commercial strategy.

Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

Cerebras Systems Inc. shares jumped 68% in its trading debut after raising $5.5 billion in the year's largest IPO, illustrating investors' surging appetite for artificial intelligence data centers and the chips running them. Shares of the Sunnyvale, California-based company pared earlier gains to close at $311.07 each on Thursday in New York, above the $185 IPO price, after being halted earlier for volatility. Cerebras' first-time share sale raised nearly 60% more than its target when it launched, and priced above a marketed range that was revised higher on Monday. Bloomberg's Ed Ludlow joins to discuss.